Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer
Miki Gondo1, Tsutomu Sakai1, Hiroshi Tsuneoka1, Chihiro Kanehira21Department of Ophthalmology, Jikei University School of Medicine, 2Division of Radiology, Jikei University School of Medicine, Tokyo, JapanBackground: The evaluation of intravitreal bevacizumab treatment for delayed radiation maculopa...
Saved in:
Main Authors: | Gondo M, Sakai T, Tsuneoka H, Kanehira C |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/f5227cc382474f8ebf9f507187229834 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
by: Shah NV, et al.
Published: (2012) -
Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
by: Kim M, et al.
Published: (2013) -
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
by: Shah NV, et al.
Published: (2013) -
Central serous papillopathy by optic nerve head drusen
by: Ana Marina Suelves, et al.
Published: (2010) -
Case of endophthalmitis following intravitreal injections of bevacizumab
by: Shinya Komori, et al.
Published: (2010)